Tom Powles/X
Feb 8, 2025, 07:02
Tom Powles: Bladder cancer highlights at ASCOGU25
Tom Powles, Professor at the University of London and Director of Barts Cancer Centre, shared a post on X:
“Bladder cancer highlights ASCOGU25:
- Outcomes of pCR patients for gem/cis/durvalumab (NIAGARA).
- Neoadjuvant gem/cis/durvalumab in upper tract disease.
- Neoadjuvant DV/PD1 in MIBC (pCR >50%?).
- Longer OS follow up for EVP 4) Data on DDXD and new FGFR3i in pretreated patients.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 8, 2025, 07:02
Feb 8, 2025, 06:53
Feb 8, 2025, 06:51
Feb 7, 2025, 21:26
Feb 7, 2025, 21:22
Feb 7, 2025, 21:16
Feb 7, 2025, 21:14